{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F92722476-6ada-464b-9034-ebdfc5b1f11a","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Metastatic Breast Cancer \u2014 San Antonio 2024 symposium series proceedings Part 3\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/92722476-6ada-464b-9034-ebdfc5b1f11a\"></iframe>","title":"Metastatic Breast Cancer \u2014 San Antonio 2024 symposium series proceedings Part 3","description":"Dr Erika Hamilton from the Sarah Cannon Research Institute in Nashville, Tennessee, Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, Dr Joyce O\u2019Shaughnessy from the Sarah Cannon Research Institute in Dallas, Texas, and Dr Sara M Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss available and novel treatment strategies for metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. \r\n\n\nCME information and select publications https://www.researchtopractice.com/SABCS2024/mBC (here).","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/9d7bf74c-9aae-4a70-8619-4e201c3e88e8/cover.jpg"}